Radiation from CT scans may cause as many as 5% of cancers diagnosed each year in the United States, research suggests.

Some benefits include mitigation of cardiac toxicity, peripheral neuropathy, cognitive impairment, and dyspnea.

Tirzepatide was associated with better glycemic control and weight loss outcomes than semaglutide and insulin among patients with T2D.

An estimated 40 to 63 percent of sudden cardiac arrest cases could be prevented by improving unfavorable profiles.

Lorundrostat, a selective aldosterone synthase inhibitor, significantly reduced 24-hour systolic blood pressure in individuals with uncontrolled and treatment-resistant hypertension, according to ...

(HealthDay News) — Maternal hypertensive disorders of pregnancy (HDP) are associated with adverse cognitive and language development in preterm infants at 2 years’ corrected age, according to a study ...

Christina Saville, from the University of Southampton in the United Kingdom, and colleagues assessed whether hospital investment in nursing staff, to eliminate understaffing, is cost-effective. The ...

After the vasculitis clinic was established, hospitalizations for any cause dropped significantly from 70 to 51 admissions per 100 person-years.

Combined use of SGLT2 inhibitors and GLP-1 receptor agonists also significantly increased the risk for falls. (HealthDay News) — Sodium-glucose cotransporter 2 (SGLT2) inhibitor use is an ...

Despite promising adherence and persistence data, tirzepatide dose escalation was slower in the real-world than clinical trials in patients with obesity without T2D. Tirzepatide dose escalation is ...

This is the first randomized trial directly comparing pulse-modulated Holmium:YAG laser and thulium fiber laser treatment of kidney stones during ureteroscopy.

Proportion of adult managed care organizations with availability varied from 24 to 100 percent for SGLT2 inhibitors, 0 to 99 percent for GLP-1 receptor agonists. (HealthDay News) — Many Medicaid ...